Organization
Conatus Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Conatus Pharmaceuticals, Inc.
... SAN DIEGO, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) announced today that two abstracts one addressing clinical results with ...
... SAN DIEGO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development of novel medicines ...
... SAN DIEGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) has accepted invitations to participate in two upcoming investor conferences. ...
... SAN DIEGO , Aug. 29, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of ...
... GALT), DURECT Corporation (NASDAQ: DRRX), Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD), Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) Data provided by GlobalData projects that by 2026, the vast ...
... SAN DIEGO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of ...
... of 3+ active products along with 3+ companies involved. Cumberland Pharmaceuticals and Conatus Pharmaceuticals are among the major drug developers as per the current pipeline ...
... SAN DIEGO - Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) today announced that it will report financial results for the ...
Subscribe now for full coverage on Conatus Pharmaceuticals, Inc.
Start My Free Trial